PMID: 7581262Aug 1, 1995Paper

In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonist

Clinical and Experimental Hypertension : CHE
R A GabelP K Siegl

Abstract

The present study was designed to characterize the in vivo pharmacology of L-159,913 (4-[[2'-(N-benzoylsulfamoyl)biphenyl-4-yl]-5butyl-2,4-dihydr o-2- [2-(trifluoromethyl)phenyl]-3H-1,2,4-triazol-3-one); a potent All receptor antagonist. In normotensive rats, dogs, rhesus monkeys, and chimpanzees, L-159,913 inhibited All-induced elevations in blood pressure. In conscious rats, the relative potencies (ED50) were 0.51 mg/kg i.v. and 0.72 mg/kg p.o. Duration of action with single i.v. or p.o. doses exceeded 6 hr in rats. L-159,913 was 3 times less potent than losartan in rats and equipotent to losartan in monkeys. All induced elevation of plasma aldosterone in rats was also inhibited by L-159,913. L-159,913 was antihypertensive in high renin hypertensive rats (aortic coarctation). The maximum hypotensive response to an acute dose of L-159,913 (10 mg/kg, po) was equal to that of enalaprilat (0.3 mg/kg, iv) in this renin dependent animal model. In conscious normotensive dogs, L-159,913 had a moderate diuretic, natriuretic and kaliuretic response with no effect on glomerular filtration rate, effective renal plasma flow or filtration fraction, suggesting a tubular site of action. L-159,913 is a selective and potent All receptor antago...Continue Reading

References

Dec 1, 1976·The American Journal of Physiology·C S SweetS L Gaul
Apr 1, 1977·Physiological Reviews·M J Peach
Jan 1, 1979·Annual Review of Pharmacology and Toxicology·N K Hollenberg
Nov 1, 1992·Australian and New Zealand Journal of Ophthalmology·N A Locket
Apr 11, 1991·American Journal of Hypertension·P B TimmermansR R Wexler
Sep 1, 1990·Drugs·D McAreavey, J I Robertson
Dec 1, 1988·American Heart Journal·J B Kostis
Dec 1, 1982·Endocrinology·G P Brown, J G Douglas
Jun 1, 1980·The Journal of Clinical Investigation·S L SwartzT J Moore

❮ Previous
Next ❯

Citations

Jul 17, 2015·International Heart Journal·Yuichi IkedaIssei Komuro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.